ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

GRTX Galera Therapeutics Inc

0.1879
-0.0196 (-9.45%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Galera Therapeutics Inc GRTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0196 -9.45% 0.1879 18:55:58
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.2013 0.1861 0.2165 0.1861 0.2075
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
28/3/202406:00GLOBEGalera Reports Fourth Quarter and Full Year 2023 Financial..
26/2/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202417:57EDGAR2Form SC 13D/A - General statement of acquisition of..
16/1/202417:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/11/202306:00GLOBEGalera Reports Third Quarter 2023 Financial Results and..
13/11/202313:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31/10/202307:09DJNGalera Shares Halted After FDA Says Avasopasem Needs..
31/10/202306:10EDGAR2Form 8-K - Current report
31/10/202306:00GLOBEGalera Announces Receipt of Type A Meeting Minutes and..
26/9/202306:24EDGAR2Form 8-K - Current report
22/9/202316:12EDGAR2Form 8-K - Current report
18/9/202306:00GLOBEGalera Schedules Type A Meeting with FDA to Discuss Next..
05/9/202306:00GLOBEGalera to Participate in the H.C. Wainwright 25th Annual..
14/8/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202306:10EDGAR2Form 8-K - Current report
14/8/202306:00GLOBEGalera Reports Second Quarter 2023 Financial Results and..
10/8/202307:00EDGAR2Form 8-K - Current report
09/8/202319:10DJNStocks to Watch: Applovin, Disney, Galera Therapeutics
09/8/202316:23DJNGalera Therapeutics to Reduce Workforce by 70% to Extend..
09/8/202315:31GLOBEGalera Receives Complete Response Letter from U.S. FDA for..
05/7/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202313:15GLOBEGalera Presents Additional Chronic Kidney Disease Data from..
18/5/202307:44DJNGalera Therapeutics Gets Orphan Drug Designation for..
18/5/202307:00GLOBEGalera Announces FDA Orphan Drug Designation Granted to..
11/5/202306:00GLOBEGalera Reports First Quarter 2023 Financial Results and..
04/5/202315:01GLOBEGalera Reports Inducement Grants Under Nasdaq Listing Rule..
01/5/202306:00GLOBEGalera Expands Commercial Leadership Team

Su Consulta Reciente

Delayed Upgrade Clock